Abivax Total Current Liabilities

Abivax (ABVX) currently reports a total current liabilities of $63M as of December 2025. That compares with $94M in the prior-year period — down 33.0% year over year. Use the charts on this page to explore Abivax's total current liabilities history and peer comparisons.

Abivax's total current liabilities decreased from $94M to $63M — a 33.0% year-over-year decrease (period ending December 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Abivax reported $63M in total current liabilities as of December 2025. That compares with $94M in the prior-year period — down 33.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total current liabilities of $63M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Abivax, and consider following ABVX for alerts when major investors trade the stock.

Abivax is classified in the Healthcare sector. On total current liabilities, it currently shows $63M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ABVX with unrelated industries.